Interdisciplinary approach is a key of efficient treatment in patients with immunoinflammatory diseases. Case report

Cover Page

Cite item

Full Text

Abstract

The article is devoted to clinical case of concomitant immune-inflammatory diseases: Crohn disease, ankylosing spondylitis, primary sclerosing cholangitis. Chronic immunoinflammatory diseases (CID) caused disability, characterized by similar genetic and immunological factors. The emergence of genetically engineered biological drugs has changed the prognosis for both musculo-skeletal diseases and inflammatory bowel disease (IBD). The intersection of the therapeutic spectrum in CID is a very important point in choosing the tactics of management of patients with these pathologies. This clinical case demonstrates the importance of early diagnosis of immunoinflammatory diseases and application of genetically engineered biological drugs, that contributes to prevention disability and enhancement of quality of life of IBD patients. It is concluded that treatment of immunoinflammatory diseases should be carried out taking into account the course of the IBD and the multidisciplinary approach, which requires close cooperation of doctors of various specialties.

About the authors

Anna V. Kagramanova

Loginov Moscow Clinical Scientific Center

Email: a.kagramanova@mknc.ru
канд. мед. наук, ст. науч. сотр. отд-ния Moscow, Russia

Oleg V. Knyazev

Loginov Moscow Clinical Scientific Center; Research Institute of Health Organization and Medical Management; Ryzhih National Medical Research Center of Coloproctology

д-р мед. наук, проф., зав. отд-нием Moscow, Russia

Dmitrii S. Kulakov

Loginov Moscow Clinical Scientific Center; Research Institute of Health Organization and Medical Management; Ryzhih National Medical Research Center of Coloproctology

мл. науч. сотр. отд-ния Moscow, Russia

Elena V. Vinnitskaya

Loginov Moscow Clinical Scientific Center

д-р мед. наук, рук. Moscow, Russia

Luliia G. Sandler

Loginov Moscow Clinical Scientific Center

ст. науч. сотр. Moscow, Russia

Nadezhda A. Savenkova

Loginov Moscow Clinical Scientific Center

канд. мед. наук, зав. отд-нием Moscow, Russia

Galina V. Lukina

Loginov Moscow Clinical Scientific Center

д-р мед. наук, проф., рук. отд. Moscow, Russia

Asfold I. Parfenov

Loginov Moscow Clinical Scientific Center

д-р мед. наук, проф., рук. отд. Moscow, Russia

References

  1. Hedin CRH, Vavricka SR, Stagg AJ, et al. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy. J Crohn's Colitis. 2019;13(5):541-54. doi: 10.1093/ecco-jcc/jjy191
  2. Парфенов А.И. Энтерология: руководство для врачей. М.: Медицинское информационное агентство, 2009
  3. Geng X, Biancone L, Dai HH, et al. Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology. 1998;114:912-22. D0I:10.1016/s0016-5085(98)70310-5
  4. Biancone L, Mandal A, Yang H, et al. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology. 1995;109:3-12. doi: 10.1016/0016-5085(95)90263-5
  5. Van Sommeren S, Janse M, Karjalainen J, et al. Extraintestinal manifestations and complications in inflammatory bowel disease: From shared genetics to shared biological pathways. Inflamm Bowel Dis. 2014;20:987-94. doi: 10.1097/MIB.0000000000000032
  6. Danese S, Semeraro S, Papa A, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11:7227-36. doi: 10.3748/wjg.v11.i46.7227
  7. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:307-27. doi: 10.1016/s0889-8553(01)00019-x
  8. Mendes FD, Levy C, Enders FB, et al. Abnormal hepatic biochemistries in patients with inflammatory bowel disease. Am J Gastroenterol. 2007;102:344-50. doi: 10.1111/j.1572-0241.2006.00947.x
  9. Хатьков И.Е., Парфенов А.И., Князев О.В., и др. Воспалительные заболевания в практике терапевта и хирурга. М., 2017; с. 70-2

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).